USP22 and liver cancer: In addition to the effect on drug resistance of liver cancer cells, other studies have also reported that USP22 can significantly affect the glycolysis and stemness characteristics of liver cancer cells under hypoxic conditions: HIF-1α knockdown inhibits USP22-induced and hypoxia-induced effects (128).